Last reviewed · How we verify
NCT04697316
Transcranial Direct Current Stimulation (tDCS) as a Cognitive Functioning Enhancement Treatment for ADHD Patients Compared to Healthy Controls
NA trial testing Transcranial Direct Current Stimulation in Transcranial Direct Current Stimulation in 63 participants. Completed in 1 June 2023.
22 November 2022
Quick facts
| Lead sponsor | Hebrew University of Jerusalem |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 63 |
| Start date | 1 August 2021 |
| Primary completion | 22 November 2022 |
| Estimated completion | 1 June 2023 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Transcranial Direct Current Stimulation
- Sham
Conditions studied
- Transcranial Direct Current Stimulation — all drugs for Transcranial Direct Current Stimulation →
Sponsor
Hebrew University of Jerusalem
Who can join
Adults 18 to 45, any sex, with Transcranial Direct Current Stimulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will examine the possible effects of tDCS (Transcranial Direct Current Stimulation) treatment to the left DLPFC on cognitive functions which were found to be deficient amongst ADHD patients. The study will include 100 subjects, 50 of whom diagnosed with ADHD. Subjects will complete the ASRS questionnaire to measure ADHD symptoms severity. Next, subjects will complete a series of cognitive tasks, after which they will receive either tDCS treatment or a sham treatment. Finally, subjects will repeat the cognitive tasks. Later that day, a telephonic follow up will take place. ADHD symptoms will be assessed again the next day.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Effect of Transcranial Direct Current Stimulation (TDCS) on Cognitive Functioning in Individuals with Attention Deficit/Hyperactivity Disorder (ADHD).
Beiman N, Eitan R, Todder D, Keha E, et al · · 2025 · cited 1× · PMID 40171119 · DOI 10.36131/cnfioritieditore20250107
Verify or expand the search:
- PubMed search for NCT04697316
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcranial Direct Current Stimulation
Trials testing the same drug.
- NCT07496645 — EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION ON NAMING IN APHASIC PATIENTS WITH ACUTE ISCHEMIC STROKE · Phase 3 · not yet recruiting
- NCT07395531 — Effect of Repetitive Bihemispheric Anodal Transcranial Direct Current Stimulation on Motor Function of Patients With Par · Phase 3 · not yet recruiting
- NCT07212634 — Cerebellar Transcranial Direct Current Stimulation for Dysphagia After Supratentorial Stroke · NA · not yet recruiting
- NCT07319143 — The Effect of Transcranial Direct Current Stimulation (tDCS) in Improving Emotion Health · NA · recruiting
- NCT06039605 — Priming Expectations and Motor Learning With tDCS · NA · completed
Other recruiting trials for Transcranial Direct Current Stimulation
Currently open trials in the same condition.
- NCT06517706 — Brain Research and Integrative Neuroscience Network for COVID-19 · NA · recruiting
- NCT06556043 — Investigating the Effects of Transcranial Direct Current Stimulation to Different Brain Regions on Ankle Tracking Motor · NA · recruiting
- NCT06505460 — Exploring the Possible Beneficial Impact of Non-invasive and Invasive Neuromodulation on Freezing of Gait in Parkinson's · NA · recruiting
- NCT06241963 — High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Refractory Epilepsy · NA · recruiting
- NCT06121635 — The Effects of Two Types of t-DCS Stimulation on Robot-assisted Gait Training in Patients With Multiple Sclerosis · NA · active not recruiting
Other Hebrew University of Jerusalem trials
Trials by the same sponsor.
- NCT07003282 — A Study to Test Feasibility and Acceptability of an Intervention Program Aiming to Reduce Prenatal Secondhand Smoke Expo · NA · recruiting
- NCT05771545 — Telepsychiatry to Enable Expedited Disposition of Psychiatric Emergencies · active not recruiting
- NCT05447091 — Examining the Effectiveness of a Tablet Video Game on Mood and Cognition · NA · completed
- NCT07025603 — Evaluation of the Social ABCs in Israel · NA · completed
- NCT04376918 — Bag-Valve-Guedel Adaptor Vs Common Face Mask for the Ventilation of Anesthetized Bearded Men · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04697316 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hebrew University of Jerusalem
- Last refreshed: 7 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04697316.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing